Flambeau Medical, a full-service, contract manufacturing organization serving the medical device and life science industries is growing in Phoenix. The company provides a full suite of development and manufacturing capabilities in FDA registered and ISO-13485:2016 certified manufacturing operations.Continue reading
Author Archive: AZBio
Suresh Garimella to become the 23rd president of the University of Arizona
The Arizona Board of Regents has appointed Suresh Garimella as the 23rd president of the University of Arizona.Continue reading
CMS Publishes Final TCET Rule to Guide Medtech Innovators
In June of 2023, the comment period for the proposed rule on Transitional Coverage for Emerging Technologies (TCET) through the national coverage determination (NCD) process under the Social Security Act closed. The draft rule has been released for public inspection and the final rule will be published on August 12, 2024.Continue reading
Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the successful completion of its WAVE pre-clinical trial. The Accelerate WAVE system is designed to deliver rapid antimicrobial susceptibility testing (“AST”) directly from positive blood culture (“PBC”) bottles and bacterial isolated colonies (“Isolates”) to report accurate results within 4.5 hours, on average.Continue reading
Anivive Receives NIAID Contract Worth Up to $33M to Progress Valley Fever Vaccine
LONG BEACH, Calif., Aug. 2, 2024 /PRNewswire/ – Anivive Lifesciences Inc, a One Health technology company today announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded Anivive a new contract (#75N93024C00009) worth up to $33M to support the development of a vaccine against the fungus Coccidioides, which causes Valley Fever.Continue reading
AZMN Founders to Receive the 2024 AZBio Service Award
Jack and Barbara Kavanagh, founders of the Arizona Myeloma Network and Cancer Caregivers of America, will be honored with the AZBio Service Award at the 20th annual AZBio Awards on September 18, 2024 at the Phoenix Convention Center.Continue reading
Valley Fever: Stakeholders Explore Developing Vaccines for Fungal Diseases
The FDA, NIH, and CDC will bring together a diverse group of stakeholders to summarize progress toward developing vaccines against fungal diseases, with an emphasis on our current understanding of the epidemiology, biology, and immunology of Valley feverContinue reading
ACA Supercharges Support For Arizona Startups
- New venture programs launched to scale Arizona Innovation Challenge
- Applications for the next round of the Arizona Innovation Challenge opened August 1, 2024 and close August 30, 2024.
Protein Homeostasis May Hold the Key to More Successful Treatment of Heart Disease
Coronary artery disease (CAD) is the most common form of heart disease, the leading cause of death for both men and women. Of the roughly 695,000 people who died from heart disease in 2021, more than 375,000 deaths were attributable to CAD, according to the Centers for Disease Control and Prevention (CDC).Continue reading
James Goulka named President & CEO of Arizona Venture Development Corp (AVC)
As President & CEO, James “Jim” Goulka leads AVC’s initiatives to invest in early-stage technology startups and funds across enterprise, software, consumer, climate-tech, and bio/health tech—all while helping catalyze access to equity capital for underserved founders and communities in Arizona.Continue reading